Suscribirse

Marked Reduction in 30-Day Mortality Among Elderly Patients with Community-acquired Pneumonia - 19/08/11

Doi : 10.1016/j.amjmed.2010.08.019 
Gregory W. Ruhnke, MD, MS, MPH a, , Marcelo Coca-Perraillon, MA b, Barrett T. Kitch, MD, MPH c, d, David M. Cutler, PhD b, e
a Section of Hospital Medicine, University of Chicago, Ill 
b National Bureau of Economic Research, Cambridge, Mass 
c Mongan Institute for Health Policy, Massachusetts General Hospital, Boston 
d North Shore Medical Center, Salem, Mass 
e Harvard University, Cambridge, Mass 

Requests for reprints should be addressed to Gregory W. Ruhnke, MD, MS, MPH, Section of Hospital Medicine, University of Chicago, 5841 South Maryland Avenue, MC 5000, Chicago, IL 60637

Abstract

Background

Community-acquired pneumonia is the most common infectious cause of death in the US. Over the last 2 decades, patient characteristics and clinical care have changed. To understand the impact of these changes, we quantified incidence and mortality trends among elderly adults.

Methods

We used Medicare claims to identify episodes of pneumonia, based on a validated combination of diagnosis codes. Comorbidities were ascertained using the diagnosis codes located on a 1-year look back. Trends in patient characteristics and site of care were compared. The association between year of pneumonia episode and 30-day mortality was then evaluated by logistic regression, with adjustment for age, sex, and comorbidities.

Results

We identified 2,654,955 cases of pneumonia from 1987-2005. During this period, the proportion treated as inpatients decreased, the proportion aged ≥80 years increased, and the frequency of many comorbidities rose. Adjusted incidence increased to 3096 episodes per 100,000 population in 1999, with some decrease thereafter. Age/sex-adjusted mortality decreased from 13.5% to 9.7%, a relative reduction of 28.1%. Compared with 1987, the risk of mortality decreased through 2005 (adjusted odds ratio, 0.46; 95% confidence interval, 0.44-0.47). This result was robust to a restriction on comorbid diagnoses assessing for the results' sensitivity to increased coding.

Conclusions

These findings show a marked mortality reduction over time in community-acquired pneumonia patients. We hypothesize that increased pneumococcal and influenza vaccination rates as well as wider use of guideline-concordant antibiotics explain a large portion of this trend. © 2011 Elsevier Inc. All rights reserved.

El texto completo de este artículo está disponible en PDF.

Keywords : Community-acquired pneumonia, Mortality, Trends


Esquema


 Funding: This work was supported by unrestricted grants P01 AG31098, P30 AG12810, and P01AG005842 from the National Institute on Aging. It also was supported by an institutional Ruth L. Kirschstein National Research Service Award (T32 HP11001) from the Health Resources and Services Administration of the Department of Health and Human Services, the Division of General Internal Medicine at the Massachusetts General Hospital, and grant F32 HS016948-01 from the Agency for Healthcare Research and Quality. The supporters had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
 Conflict of Interest: The authors confirm the absence of potential conflicts of interest, financial or otherwise.
 Authorship: All authors had access to the data and a role in writing the manuscript. Dr. Ruhnke had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.


© 2011  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 124 - N° 2

P. 171 - février 2011 Regresar al número
Artículo precedente Artículo precedente
  • Association between Social Isolation and Left Ventricular Mass
  • Carlos J. Rodriguez, Mitchell S.V. Elkind, Lynn Clemow, Zhezhen Jin, Marco Di Tullio, Ralph L. Sacco, Shunichi Homma, Bernadette Boden-Albala
| Artículo siguiente Artículo siguiente
  • Randomized Trial of a Warfarin Communication Protocol for Nursing Homes: an SBAR-based Approach
  • Terry S. Field, Jennifer Tjia, Kathleen M. Mazor, Jennifer L. Donovan, Abir O. Kanaan, Leslie R. Harrold, George Reed, Peter Doherty, Ann Spenard, Jerry H. Gurwitz

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.